BRIEF-Immunicum includes first patient in a phase II study in patients with metastatic kidney cancer

<span id="midArticle_start"/>May 5 (Reuters) - Immunicum AB :

<span id="midArticle_0"/>* Includes first patient in a phase II study in patients with metastatic kidney cancer

<span id="midArticle_1"/>* Plans to include a total of 90 patients at 20 European centers

<span id="midArticle_2"/>Source text for Eikon:

<span id="midArticle_3"/>Further company coverage: (Gdynia Newsroom)

<span id="midArticle_4"/>

via Smart Health Shop Forum http://ift.tt/1EN2Yfj